Previous 10 | Next 10 |
ANI Pharmaceuticals, Inc. (ANIP) Q1 2022 Earnings Conference Call May 10, 2022 8:30 a.m. ET Company Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President and Chief Executive Officer Steve Carey - Chief Financial Officer Chris Mutz - Head of Rare Disease Conference Call Part...
ANI Pharmaceuticals press release (NASDAQ:ANIP): Q1 Non-GAAP EPS of -$0.12 misses by $0.21. Revenue of $64.48M (+18.3% Y/Y) misses by $0.55M. Provides Purified Cortrophin® Gel 2022 Net Revenue guidance of $35 million to $40 million, Total Company Net Revenue guidance of $295 million...
-- First quarter net revenues of $64.5 million, net loss of $(20.1) million and diluted GAAP loss per share of $(1.27) -- -- First quarter adjusted non-GAAP EBITDA of $4.3 million and adjusted non-GAAP diluted loss per share of $(0.12) -- -- Provides Purified Cortrophi...
ANI Pharmaceuticals (NASDAQ:ANIP) is scheduled to announce Q1 earnings results on Tuesday, May 10th, before market open. The consensus EPS Estimate is $0.09 (-91.3% Y/Y) and the consensus Revenue Estimate is $65.03M (+19.3% Y/Y). Over the last 2 years, ANIP has beaten EPS estimates 63% of the...
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2022 financial results on Tuesday, May 10, 2022. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey,...
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Misoprostol Tablets, 100 mcg and 200 mcg. ANI’s Misoprostol Tablets are the generic version of the Reference Listed Drug (RLD) Cytotec ® . The ...
Shares of ANI Pharmaceuticals Inc. (NASDAQ:ANIP) traded today at $86.44, eclipsing its 52-week high. Approximately 12.2 million shares have changed hands today, as compared to an average 30-day volume of 187,000 shares. ANI Pharmaceuticals Inc. (NASDAQ:ANIP) is currently priced 2.0% abov...
Shares of ANI Pharmaceuticals Inc. (NASDAQ:ANIP) traded at a new 52-week high today of $86.44. This new high was reached on above average trading volume as 12.2 million shares traded hands, while the average 30-day volume is approximately 188,000 shares. Based on a current price of $28.9...
“Meme stocks” GameStop and AMC Entertainment saw their stocks surge last week. GameStop registered a gain of over 67% for the week. Billionaire founder of online pet retailer Chewy, Ryan Cohen, Alain Attal, a Chewy executive, and Lawrence Cheng, a Managing Partner of...
-- Dr. Tannenbaum’s successful track record in driving commercial excellence to contribute as Company executes Purified Cortrophin Gel TM launch -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced the addition of Renee P. Tannenbaum, P...
News, Short Squeeze, Breakout and More Instantly...
ANI Pharmaceuticals Inc. Company Name:
ANIP Stock Symbol:
NASDAQ Market:
ANI Pharmaceuticals Inc. Website:
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) and launched Naproxen Delayed-Release Tablets, USP....
PRINCETON, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that its Chief Executive Officer, Nikhil Lalwani, has been named an Ernst & Young LLP (EY US) Entrepreneur Of The Year ® 2024 New Jersey Award winner. Entr...
2024-06-24 08:08:29 ET Alimera Sciences Inc (NASDAQ: ALIM) rallied a whopping 75% in premarket today after ANI Pharmaceuticals Inc (NASDAQ: ANIP) said it will buy the Alpharetta, Georgia based company for about $381 million. ANI shares are roughly flat at writing. Alimera Sc...